The application proposes to continue an ongoing investigation of a newly identified autosomal dominant (AD) epilepsy syndrome with auditory features (ADPEAF). A susceptibility gene for this syndrome was recently localized to a 10 centimorgan region of chromosome 10q. The current plan is to ascertain and clinically characterize 5-10 additional extended pedigrees with ADPEAF, comprising approximately 100 living subjects (35 affected), and to confirm and refine the localization of the susceptibility gene by performing linkage analysis in these families. Families will be ascertained through four methods: 1) screening of the computerized database of epilepsy patients at the applicant institution; 2) yearly mailings to the membership of the American Epilepsy Society; 3) publication of an article in Epilepsy USA, the newspaper of the Epilepsy Foundation of America; and 4) requests for referrals in presentations given by the applicant. Families will be included in the analysis only if they contain 3 or more individuals with partial epilepsy with auditory features, similar to those in the original pedigree of this study. The applicants will test each family for linkage with the same markers on chromosome 10q and the same genetic model as in the previous analysis. If evidence for linkage is found, they will search for recombination events that further narrow the region containing the locus. Local heterogeneity will be assessed by determining the proportion of families with evidence for linkage to chromosome 10q and localizing susceptibility genes for ADPEAF to other regions in families that do not show evidence for linkage. In families with evidence for linkage to chromosome 10q, the applicants will test the hypothesis that the susceptibility gene raises risk for other seizure disorders in addition to ADPEAF (e.g., generalized epilepsies, isolated unprovoked seizures, febrile convulsions, and/or alcohol-related seizures), by comparing the proportion affected with these disorders among individuals likely, and not likely, to be gene carriers.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Jacobs, Margaret
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Schools of Medicine
New York
United States
Zip Code
Dazzo, Emanuela; Fanciulli, Manuela; Serioli, Elena et al. (2015) Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. Am J Hum Genet 96:992-1000
Helbig, Ingo; Hodge, Susan E; Ottman, Ruth (2013) Familial cosegregation of rare genetic variants with disease in complex disorders. Eur J Hum Genet 21:444-50
Ho, Yuan-Yuan; Ionita-Laza, Iuliana; Ottman, Ruth (2012) Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF. Neurology 78:563-8
Van Gompel, Jamie J; Ottman, Ruth; Worrell, Gregory A et al. (2012) Use of anterior temporal lobectomy for epilepsy in a community-based population. Arch Neurol 69:1476-81
Ionita-Laza, Iuliana; Ottman, Ruth (2011) Study designs for identification of rare disease variants in complex diseases: the utility of family-based designs. Genetics 189:1061-8
Shostak, Sara; Zarhin, Dana; Ottman, Ruth (2011) What's at stake? Genetic information from the perspective of people with epilepsy and their family members. Soc Sci Med 73:645-54
Madsen, Ann M; Ottman, Ruth; Hodge, Susan E (2011) Causal models for investigating complex genetic disease: II. what causal models can tell us about penetrance for additive, heterogeneity, and multiplicative two-locus models. Hum Hered 72:63-72
Madsen, Ann M; Hodge, Susan E; Ottman, Ruth (2011) Causal models for investigating complex disease: I. A primer. Hum Hered 72:54-62
Ottman, Ruth; Hirose, Shinichi; Jain, Satish et al. (2010) Genetic testing in the epilepsies--report of the ILAE Genetics Commission. Epilepsia 51:655-70
Heiman, Gary A; Kamberakis, Kay; Gill, Richard et al. (2010) Evaluation of depression risk in LGI1 mutation carriers. Epilepsia 51:1685-90

Showing the most recent 10 out of 23 publications